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Abstract 
Background: Scaling up diagnostic testing and treatment is a key strategy to reduce the burden of malaria. Delays 
in accessing treatment can have fatal consequences; however, few studies have systematically assessed these delays 
among children under five years of age in malaria-endemic countries of sub-Saharan Africa. This study identifies pre-
dictors of prompt treatment with first-line artemisinin combination therapy (ACT) and describes profiles of children 
who received this recommended treatment.
Methods: This study uses data from the most recent Demographic and Health Survey, Malaria Indicator Survey, or 
Anaemia and Parasite Prevalence Survey conducted in 13 countries. A Chi square automatic interaction detector 
(CHAID) model was used to identify factors associated with prompt and effective treatment among children under 
five years of age.
Results: The percentage of children with fever who received any anti-malarial treatment varies from 3.6 % (95 % CI 
2.8–4.4 %) in Ethiopia to 64.5 % (95 % CI 62.7–66.2 %) in Uganda. Among those who received prompt treatment with 
any anti-malarial medicine, the percentage who received ACT ranged from 32.2 % (95 % CI 26.1–38.4 %) in Zambia 
to nearly 100 % in Tanzania mainland and Zanzibar. The CHAID analysis revealed that country of residence is the best 
predictor of prompt and effective treatment (p < 0.001). Depending on the country, the second best predictor was 
maternal education (p = 0.004), place of residence (p = 0.008), or household wealth index (p < 0.001).
Conclusions: This study reveals that country of residence, maternal education, place of residence, and socio-eco-
nomic status are key predictors of prompt access to malaria treatment. Achieving universal coverage and the elimi-
nation agenda will require effective monitoring to detect disparities early and sustained investments in routine data 
collection and policy formulation.
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Background
Malaria burden remains high in sub-Saharan Africa 
(SSA) and affects mostly children under five years of age 
[1]. Several strategies have been proposed to reduce this 
burden, including improved vector control, intermittent 
preventive treatment during pregnancy, and standard-
ized case management. For these interventions to be 
most effective, however, they must reach national and 
global coverage targets [2].
The World Health Organization (WHO) recommends 
prompt treatment, usually within 24  h of the onset of 
fever, with recommended anti-malarial medicines after 
confirmation of malaria through appropriate diagnos-
tic tests [1]. Timely access to effective treatment with 
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first-line artemisinin combination therapy (ACT) is fun-
damental to preventing progression of Plasmodium fal-
ciparum malaria to severe malaria and death, particularly 
among children under five years of age. Across SSA, only 
a small proportion of malaria patients, including children, 
receive prompt and effective treatment [1]. In Kenya, a 
systematic review documented a delay in treatment for 
fever, with only 5 % of fever cases receiving prompt treat-
ment with an anti-malarial drug [3]. Similarly, in Tanza-
nia, Khatib and colleagues found that less than 50  % of 
fever cases received treatment with ACT within 24 h [4]. 
Potential reasons for low access to prompt and effective 
treatment among children revolve around affordability, 
acceptability, availability, and adequacy to meet expecta-
tions in quality of care [5–9].
Several studies have looked into a specific context, 
dimension, or population related to prompt and effec-
tive treatment for malaria; however, few studies sys-
tematically look across all children in SSA [10, 11]. This 
study aims to fill this gap by examining the extent to 
which children under five years of age in selected coun-
tries in SSA received prompt and effective treatment and 
describing profiles of children who received this recom-
mended treatment. The study also identifies subgroups 
that, when successfully targeted, may optimize benefits of 
interventions within the entire population. Although no 
longer recommended as a key malaria control indicator 
due to challenges in its interpretation [12], ‘promptness’ 
was assessed by whether treatment commenced the same 
day or day after onset of fever. The work involves the 
following US President’s Malaria Initiative (PMI) focus 
countries that have relevant national survey data and 
that were selected for impact evaluations: Angola, Benin, 
Ethiopia, Ghana, Kenya, Liberia, Madagascar, Malawi, 
Mali, Mozambique, Rwanda, Senegal, United Republic of 
Tanzania (mainland and Zanzibar), Uganda, and Zambia.
Methods
Data used for the analysis
This study uses data from the most recent Demographic 
and Health Survey (DHS), Malaria Indicator Survey 
(MIS), or Anaemia and Parasite Prevalence Survey 
(A&PS) conducted in each PMI priority country. Each of 
these surveys included a malaria module, in addition to 
the standard household and women’s questionnaires. All 
surveys were conducted between 2006 (Benin) and 2012 
(Malawi), with most carried out in 2010 and 2011. The 
countries belong to three geographical regions of SSA: (1) 
west, (2) central, and (3) east (Fig. 1).
Anti‑malarial drug policies
All countries had adopted ACT as first-line treatment 
for malaria (‘effective treatment’) by the time the surveys 
were conducted; however, the duration between policy 
adoption and the survey varies from 2  years (Benin) to 
7  years (Liberia, Ethiopia, and Mozambique), with an 
average of 5.2 years (Table 1).
Data quality checks
Data quality checks included assessing response rates, 
evaluating completeness of data for key variables, and 
assessing reliability of birth history data. Response rates 
refer to the percentage of the number of people or house-
holds in the sample that completed an interview. In each 
country, more than 90  % of identified households and 
women were successfully interviewed, confirming ade-
quate response rates. Misreporting of ages or dates of 
birth can affect malaria estimates because malaria infec-
tion varies significantly by a child’s age [13, 14]. In each 
country included in the study, at least 93  % of children 
had complete month and year of birth data, so no country 
was eliminated due to incomplete information. The reli-
ability of maternal reporting was assessed by analysing 
the number of live births per year. Overall, the number of 
births was high for the 4 years preceding the survey but 
lower in the fifth year preceding the survey. This distribu-
tion did not, however, affect the overall reliability of the 
birth history data.
Of 16 countries, 14 had information on whether anti-
malarial treatment was received on the same or next day 
as the onset of fever (‘prompt treatment’). Two countries, 
Ethiopia and Mali, were excluded from the bivariate and 
multivariate analyses because they do not include this 
information. In addition, the Benin database did not have 
time-to-treatment for ACT and was excluded from some 
analyses.
Statistical analysis
The analysis included two steps. The first step involved 
computing proportions and conducting Chi square tests 
for each country to identify associations between prompt 
treatment and selected background characteristics of 
children, their primary caretakers, and their households. 
The data was weighted to account for oversampling, 
undersampling, and varying response in different regions 
included in national household surveys. The second step 
consisted of pooling data from all countries and running 
a Chi square automatic interaction detector (CHAID) 
model [15, 16]. This method is a sequential fitting algo-
rithm; at each step, the model chooses the predictor vari-
able that has the strongest interaction with an outcome 
of interest: here, prompt and effective treatment. The 
variable with the strongest association becomes the first 
branch of the tree, with a leaf for each category that is 
significantly different. CHAID then assesses the cate-
gory groupings to pick the most significant combination 
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of variables. It is particularly useful for identifying sub-
groups that are more or less likely to experience the 
outcome of interest and for determining the relative con-
tributions of these groups to overall coverage in the gen-
eral population.
The analysis was restricted to children with fever who 
received any anti-malarial medicine. The covariates were 
the child’s sex, age group in months (<6, 6–23, 24–59), 
relationship to the head of household (child or stepchild, 
grandchild, other), maternal age in years (15–19, 20–29, 
30–49), maternal education (none, primary, secondary 
and above), place of residence (urban, rural), household 
wealth quintiles, and country of residence.
The output of the CHAID model is presented in a 
hierarchical tree structure and consists of several levels 
of branches: root node, parent nodes, child nodes, and 
Fig. 1 Countries and household surveys included in the study
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terminal nodes. The root node, ‘Node 0’, comprises chil-
dren who received any anti-malarial medicine. Parent 
nodes are upper nodes compared to lower-level child 
nodes. Terminal nodes are any node that does not have 
child nodes. For each terminal node, the CHAID model 
provides the following indicators: (1) demographic 
weight in the sample; (2) gain, the number of children 
who received prompt and effective treatment in the ter-
minal node, divided by the total number of children who 
received any anti-malarial treatment; (3) response, the 
proportion of children who received prompt and effective 
treatment among all those within the terminal node; and, 
(4) gain index percentage, which represents the increased 
probability of prompt and effective treatment in the ter-
minal node compared to the overall study population.
Results
Treatment of fever among children under five
Among children with fever, the proportion that received 
any anti-malarial treatment varied from 3.6  % (95  % CI 
2.8–4.4  %) in Ethiopia to 64.5  % (95  % CI 62.7–66.2  %) 
in Uganda. Coverage was above 50  % in four countries: 
Benin, Liberia, Tanzania mainland, and Uganda. The 
percentage of children with fever who received an ACT 
was below 10 % in nearly half of the countries included 
in the analysis. Higher percentages of children received 
an ACT in Uganda (44.2 %, 95 % CI 42.4–46.1 %), Libe-
ria (39.7 %, 95 % CI 37.3–42.1 %), and Tanzania mainland 
(37.9 %, 95 % CI 35.1–40.6 %). Coverage was particularly 
low in Benin (0.9 %, 95 % CI 0.6–1.1 %), where ACT was 
rolled out in 2004, just 2 years before the survey [17]. The 
percentage of children who received ACT, among those 
who received any anti-malarial treatment, varied from 
1.6  % (95  % CI 1.1–2.1  %) in Benin to 95.7  % (95  % CI 
92.3–99.1 %) in Rwanda (Table 2).
Prompt treatment of fever among children under five
The percentage of children who received prompt treat-
ment, among children who received any anti-malarial 
drug, varied from 42.1 % (95 % CI 34.8–49.4 %) in Mad-
agascar to 87.2  % (95  % CI 76.7–97.8  %) in Zanzibar. 
Among those who received prompt treatment with any 
anti-malarial medicine, the percentage who received 
ACT ranged from 32.2 % (95 % CI 26.1–38.4 %) in Zam-
bia to nearly 100 % in Tanzania mainland and Zanzibar 
(Table 3).
Region of residence or type of place of residence were 
significantly associated with access to prompt treatment 
with any anti-malarial medicine in ten countries, mak-
ing geography the most frequent association. In Angola, 
Benin, and Uganda, urban residence was significantly 
associated with prompt treatment (p value  =  0.042, 
p value <0.0001, and p value  =  0.039, respectively), 
whereas in Liberia, more rural children received prompt 
treatment (p value = 0.025).
Wealth quintile was significantly associated with 
prompt treatment in six countries. In most of these coun-
tries, children in the two highest wealth quintiles were 
most likely to receive prompt treatment. In contrast, chil-
dren in the lowest wealth quintile in Angola and Liberia 
were most likely to have received prompt treatment (p 
value = 0.030 and p value <0.0001, respectively).
Table 1 Duration between year of ACT policy adoption and implementation of surveys
ALu artemether–lumefantrine, ASAQ arthesunate–amodiaquine
Country Type of ACT Year adopted Year of survey Time in years between  
policy adoption and survey
Angola ALu 2006 2011 5
Benin ALu 2004 2006 2
Ethiopia ALu 2004 2011 7
Ghana ASAQ, ALu 2004 2008 4
Kenya ALu 2004 2009 5
Liberia ALu 2004 2011 7
Madagascar ASAQ 2006 2011 5
Malawi ASAQ, ALu 2007 2012 5
Mali ASAQ, ALu 2007 2010 3
Mozambique ALu 2004 2011 7
Rwanda ALu 2005 2010 5
Senegal ASAQ 2005 2011 5
Tanzania mainland ALu, ASAQ 2004 2010 6
Uganda ALu 2004 2011 6
Zambia ALu 2002 2007 5
Zanzibar ASAQ 2004 2010 6
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Maternal characteristics were associated with prompt 
treatment with any anti-malarial medicine in some coun-
tries. In general, the percentage of children who received 
prompt treatment was high among children whose moth-
ers had at least a secondary education. In Kenya and 
Mozambique, prompt access to treatment with any anti-
malarial medicine was significantly lower among children 
with mothers aged 15–19 years and higher among those 
with mothers aged 20–29  years (p value =  0.043 and p 
value < 0.0001, respectively).
Children’s demographic characteristics were less 
likely to be significantly associated with prompt access 
to anti-malarial treatment. In Ghana, more male chil-
dren received prompt treatment than female children 
(p value  =  0.049). In contrast, more female children in 
Senegal received prompt treatment compared to males 
(p value = 0.046). In Tanzania mainland, the percentage 
of children who received prompt treatment was signifi-
cantly higher among children ages 24–59  months com-
pared to younger children (p value = 0.056) (Table 4).
Profiling children under five who received prompt 
treatment with ACT
To identify the socio-economic profile of children who 
received prompt and effective treatment, data from all 
children who received any anti-malarial drug across the 
13 countries were pooled. Eight independent variables 
were examined, but only five were included in the final 
model. The model comprised 20 nodes, of which 13 were 
terminal nodes. Parent nodes included at least 100 chil-
dren, whereas child nodes included at least 50 children.
Country was the best predictor of access to prompt 
treatment with ACT (p value <0.0001) and therefore 
makes up the first level of the CHAID tree diagram. The 
analysis classified countries into six parent nodes that 
minimize variance of prompt and effective treatment 
within each node and maximize variance across nodes: 
(1) Angola, Ghana, and Zambia; (2) Kenya and Madagas-
car; (3) Liberia; (4) Malawi, Rwanda, Senegal, and Tan-
zania mainland; (5) Mozambique and Zanzibar; and, (6) 
Uganda. At the next levels of the CHAID tree diagram, 
these parent nodes were further split into child nodes by 
secondary and tertiary predictor variables, which were 
most commonly education of the mother or wealth quin-
tile (Figs. 2, 3, 4, 5, 6, 7).
In Node 1–Angola, Ghana, and Zambia (Fig. 3), educa-
tion level of the mother was the best predictor of prompt 
treatment with ACT (p value = 0.009). Among children 
whose mothers had secondary education or higher (Node 
7), 61.5 % received prompt treatment with ACT. Among 
children whose mothers had primary education or less 
(Node 8), 51.6  % received prompt treatment with ACT. 
Table 2 Percentage of children under five with fever in the 2 weeks before the survey who received treatment with anti-
malarial drug by country
95 % CI 95 % confidence interval, N number of children
a Artemisinin combination therapy [ACT] was rolled out in Benin only 2 years before the survey
Country Children with fever in the 2 weeks before the survey Children who received ACT among those 
who received any anti‑malarial treatment
Received any anti‑malarial Received ACT % (95% CI) N Year
% (95% CI) % (95% CI) N
Angola 28.3 (26.6–30.0) 21.7 (20.1–23.2) 2645 76.6 (73.5–79.6) 738 2011
Benina 54.0 (52.5–55.5) 0.9 (0.6–1.1) 4204 1.6 (1.1–2.1) 2243 2006
Ethiopia 3.6 (2.8–4.4) 1.3 (0.8–1.8) 2082 36.3 (27.8–44.9) 124 2011
Ghana 43.0 (38.8–47.1) 21.5 (18.1–24.9) 551 50.0 (44.5–56.6) 225 2008
Kenya 23.2 (20.9–25.4) 7.8 (6.3–9.2) 1385 33.5 (28.2–38.7) 311 2009
Liberia 57.1 (54.7–59.5) 39.7 (37.3–42.1) 1617 69.6 (66.5–72.6) 895 2011
Madagascar 19.8 (17.3–22.4) 3.8 (2.6–5.0) 959 19.3 (13.4–25.1) 177 2011
Malawi 32.5 (29.0–36.0) 29.6 (26.1–33.0) 676 91.0 (87.1–94.8) 216 2012
Mali 34.7 (31.2–38.2) 7.8 (5.8–9.7) 705 22.4 (17.1–27.6) 243 2010
Mozambique 29.9 (27.4–32.4) 17.9 (15.8–20.0) 1313 59.9 (54.9–64.9) 366 2011
Rwanda 10.8 (9.2–12.5) 10.4 (8.7–12.0) 1332 95.7 (92.3–99.1) 140 2010
Senegal 8.2 (7.1–9.3) 3.4 (2.6–4.1) 2314 41.0 (33.7–48.3) 176 2010
Tanzania mainland 60.1 (57.4–62.7) 37.9 (35.1–40.6) 1320 63.1 (59.7–66.5) 785 2010
Uganda 64.5 (62.7–66.2) 44.2 (42.4–46.1) 2860 68.6 (66.5–70.7) 1849 2010
Zambia 38.4 (35.4–41.3) 11.1 (9.2–13.0) 1034 29.0 (24.6–33.4) 417 2007
Zanzibar 16.9 (12.5–21.3) 5.6 (2.9–8.3) 282 33.1 (18.3–48.0) 42 2010
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Household wealth quintile was also a predictor variable 
in Node 8 (p value =  0.029), with 55.4 % of children in 
the lowest, fourth, and highest wealth quintiles (Node 18) 
receiving prompt treatment with ACT, compared to only 
45.4 % of their counterparts in the second and third quin-
tiles (Node 19).
Education level of the mother was also the best pre-
dictor in Node 2–Kenya and Madagascar (Fig.  4) (p 
value =  0.036), with 56.8  % of children whose mothers 
had at least a secondary education (Node 9) receiving 
prompt treatment with ACT, compared to just 43.2  % 
of children whose mothers had primary education or 
less (Node 10). About 7.7  % of children who received 
any anti-malarial treatment live in these two countries, 
46.3 % of whom received prompt treatment with ACT.
For children in Node 3–Liberia (Fig.  5), household 
wealth quintile was the best predictor of prompt treat-
ment with ACT (p value <0.0001). About 67.7 % of chil-
dren from the highest and lowest quintiles (Node 11), 
48.3 % of children from the fourth quintile (Node 12), and 
59.1  % of children from the second and third quintiles 
(Node 13) received prompt treatment with ACT. Chil-
dren in Liberia represent 14.1  % of those who received 
any anti-malarial treatment.
Country was the only predictor for children in Node 
4–Malawi, Rwanda, Senegal, and Tanzania mainland 
(Fig. 2); therefore, Node 4 is terminal. This group repre-
sents 20.8 % of children who received treatment with any 
anti-malarial medicine. Among these children, 71.1  % 
received prompt treatment with ACT.
In Node 5–Mozambique and Zanzibar (Fig.  6), age of 
the mother was the best predictor of prompt treatment 
with ACT (p value <0.0001). The proportion of children 
who received prompt treatment with ACT was signifi-
cantly higher (85.9  %) among those with mothers ages 
20–29  years (Node 14) compared to their younger and 
older counterparts in Node 15 (75.1 %, p value = 0.018). 
Children living in Mozambique and Zanzibar comprised 
just 6.4  % of children who received any anti-malarial 
treatment.
Place of residence was the best predictor in Node 6–
Uganda (Fig. 7), with 71.1 % of children receiving prompt 
treatment with ACT in urban areas (Node 16) compared 
to 66.0  % in rural areas (Node 17) (p value  =  0.039). 
Ugandans made up 10.5  % of all children who were 
treated with any anti-malarial medicine; 67.1 % of these 
children received prompt treatment with ACT.
Chi square automatic interaction detector gain index
The gain index from the CHAID analysis can help high-
light whether it is more efficient to target specific groups 
or to invest in the overall population, with potential 
trickle-down effects to those groups. The 13 terminal 
nodes of the CHAID tree diagram represent 13 homog-
enous sub-groups of children who received any anti-
malarial treatment, grouped into three major clusters 
(Table 5).
Cluster 1 comprises children from urban areas in 
Uganda plus all children in Mozambique, Zanzibar, 
Malawi, Rwanda, Senegal, and Tanzania. This cluster rep-
resents 32.5  % of children who received treatment with 
any anti-malarial medicine, among which 73.0 % of chil-
dren received prompt treatment with ACT. This group 
accounts for 37.5 % of all children who received prompt 
treatment with ACT.
Cluster 2 includes children in all but the fourth wealth 
quintile in Liberia; children from rural areas in Uganda; 
children from mothers with a secondary education and 
above in Angola, Ghana, Zambia, Kenya, and Madagas-
car; and children from the lowest, fourth, and highest 
wealth quintiles in Angola, Ghana, and Zambia. This 
cluster accounts for 53.1  % of children who received 
treatment with any anti-malarial medicine, among which 
Table 3 Percentage of children under five with fever in the 
2 weeks before the survey who received prompt treatment 
with anti-malarial drug by country
95 % CI 95 % confidence interval, N number of children
a Although weighted proportions are presented, the N values are unweighted 
and therefore, may not match exactly
b Children who received only ACT are excluded because the database does not 
contain information on when they started the treatment
c No information on time to treatment
Country Prompt treatment 
with any anti‑malarial 





who received prompt 
treatment with any anti‑
malarial drug
% (95% CI) Na % (95% CI) Na
Angola 57.8 (51.2–61.4) 738 72.4 (68.0–76.8) 398
Beninb 77.8 (76.0–79.5) 2243 n/a n/a
Ethiopiac n/a n/a n/a n/a
Ghana 55.2 (48.6–61.7) 225 51.0 (42.0–59.9) 124
Kenya 50.6 (50.0–56.1) 311 36.1 (28.1–44.0) 145
Liberia 61.3 (58.1–64.5) 895 69.9 (66.0–73.8) 539
Madagascar 42.1 (34.8–49.4) 177 36.6 (25.9–4.3) 81
Malawi 73.3 (67.4–79.3) 216 88.6 (83.6–93.7) 156
Malic n/a n/a n/a n/a
Mozambique 74.4 (69.9–78.9) 366 69.2 (63.9–74.5) 292
Rwanda 70.8 (63.2–78.4) 140 98.0 (95.1–100.0) 101
Senegal 73.0 (67.0–80.3) 176 47.5 (38.8–56.2) 131
Tanzania  
mainland
68.9 (66.7–72.1) 785 99.6 (99.0–100.0) 548
Uganda 65.4 (63.2–67.5) 1849 71.8 (69.3–74.4) 1240
Zambia 53.4 (48.6–58.2) 417 32.2 (26.1–38.4) 225
Zanzibar 87.2 (76.7–97.8) 42 100.0 36
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62.4  % of children received prompt treatment with 
ACT. This group accounts for 52.3 % of all children who 
received prompt treatment with ACT.
Cluster 3 includes children from the fourth wealth 
quintile in Liberia; children from mothers with primary 
or no education in Angola, Ghana, Zambia, Kenya, and 
Table 4 Socio-economic and  demographic characteristics significantly associated with  access to  prompt treatment 
with any anti-malarial drug among children under five
p values (column C) indicate that the corresponding variable (column B) is significantly associated with prompt treatment with any anti-malarial drug; categories 
in column D are those that have the highest proportion of children who received prompt treatment with any anti-malarial drug for each corresponding variable in 
column B
95 % CI 95 % confidence interval, N number of children
a Data on time to treatment was not available
b Region of residence is significantly associated with prompt treatment with any anti-malarial drug; however, the number of children for each of the 20 regions is 
fewer than 30, so percentages were not computed
c Although these values are p > 0.05, they were included because they show borderline significance
Country Variable significantly associated with prompt treatment 
with any anti‑malarial drug
Category with highest percentage of children 
who received prompt treatment with any anti‑
malarial drug
Variable p value Category % (95% CI)
A B C D E
Angola Relationship to the head of household 0.032 Grandchild 64.2 (55.3–73.2)
Education level of the mother 0.029 Secondary and above 68.1 (60.7–75.6)
Region of residence (endemicity) 0.032 Mesoendemica estavel 67.4 (61.0–75.6)
Place of residence 0.042 Urban 62.6 (57.9–67.3)
Wealth quintiles 0.030 Lowest 67.5 (54.3–80.6)
Benin Education level of the mother <0.0001 Secondary and above 85.2 (79.4–91.0)
Region of residence <0.0001 Littoral 91.0 (85.6–96.1)
Place of residence <0.0001 Urban 84.5 (81.9–87.1)
Wealth quintiles <0.0001 Highest 84.1 (80.0–88.1)
Ethiopiaa n/a n/a n/a n/a
Ghana Child’s sex 0.049 Male 59.4 (50.5–68.3)
Region of residence <0.0001 Upper east 87.0 (72.9–100.0)
Kenya Age of the mother 0.043 20–29 years 53.0 (45.3–60.6)
Education level of the mother 0.008 Secondary and above 66.5 (54.3–78.7)
Region of residence <0.0001 Central province 86.0 (63.0–100.0)
Wealth quintiles 0.023 Fourth 65.5 (51.4–79.6)
Liberia Place of residence 0.025 Rural 65.6 (61.0–70.0)
Wealth quintiles <0.0001 Lowest 69.8 (63.6–75.9)
Madagascar Region of residence <0.0001 n/ab n/a
Malawi Relationship to the head of household 0.033 Child 75.5 (69.4–81.6)
Malia n/a n/a n/a n/a
Mozambique Age of the mother <0.0001 20–29 years 79.1 (73.1–85.1)
Region of residence <0.0001 Tete 99.7 (74.3–100.0)
Rwanda Wealth quintiles 0.051c Highest 81.1 (64.6–97.6)
Senegal Child’s sex 0.046 Female 84.0 (75.1–92.9)
Tanzania mainland Child’s age 0.056c 24–59 months 73.0 (68.0–77.0)
Region of residence <0.0001 Mtwara 96.4 (89.6–100.0)
Uganda Region of residence <0.0001 Karamoja 81.1 (75.0–87.1)
Place of residence 0.039 Urban 68.6 (63.6–73.6)
Zambia Education level of the mother 0.007 Secondary and above 65.7 (56.2–75.2)
Region of residence <0.0001 Southern 78.9 (66.5–91.3)
Wealth quintiles <0.0001 Fourth 66.8 (56.9–76.8)
Zanzibara n/a n/a n/a n/a
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Madagascar; and children from the second and third 
wealth quintiles in Angola, Ghana, and Zambia. This 
cluster represents 14.4 % of children who received treat-
ment with any anti-malarial medicine. In this category, 
45.0 % of children received prompt treatment with ACT, 
representing 10.2 % of all children who received prompt 
treatment with ACT (Table 5).
Discussion
This study presented coverage of prompt treatment with 
ACT among febrile children under five years of age and 
also profiled those children who received this recom-
mended treatment in selected countries in SSA. Most 
countries with high coverage of treatment with any 
anti-malarial medicine also had high coverage of treat-
ment with ACT, perhaps since one is dependent on the 
other. Mali and Benin both depart from this trend; treat-
ment with ACT was much less likely than treatment with 
other anti-malarial drugs. This may be due to ACT hold-
ing a particularly small share of the market compared 
to other anti-malarial drugs [18] or the fact that ACT 
policy was implemented only shortly before the surveys 
were conducted [1]. These countries show how important 
policy and markets are to ensuring access to prompt and 
effective treatment for malaria.
The cross-country CHAID analysis revealed that the 
country of residence is the best predictor of prompt 
and effective treatment, followed by maternal educa-
tion, household wealth quintile, maternal age, and place 
of residence. It is perhaps unsurprising that country 
is the best predictor of prompt and effective treatment 
since malaria treatment policies differ among countries 
and are in various stages of implementation (Table  1). 
National drug regulations also affect the availability of 
anti-malarial drugs, including ACT, and may therefore 
also affect the uptake of prompt and effective treatment. 
This analysis highlights the importance of ensuring that 
first-line drug policies are synchronized with latest epi-
demiological information and are accompanied by effi-
cient rollout and awareness raising campaigns. Results 
related to country of residence may also be a reflection 
of malaria transmission and epidemiology. For example, 
Node 2 comprises Kenya and Madagascar, which are 
the only two countries in the study with a majority of 
Fig. 2 Prompt treatment with ACT among children under five treated with any anti-malarial medicine—Chi square automatic interaction detector 
tree diagram, level 1. N number of children. The total line of each box represents the share of the total number of children who received any anti-
malarial treatment
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the population living outside of high-transmission areas 
[1]. Uganda and Liberia, which have the highest parasite 
prevalence of the countries in the study, each made up 
their own node.
Children were more likely to have received prompt 
and effective treatment if their mothers had at least a 
secondary education (Angola, Ghana, Zambia, Kenya, 
and Madagascar). With the exception of Angola, these 
Fig. 3 Node 1—Angola, Ghana, and Zambia. N number of children. The total line of each box represents the share of the total number of children 
who received any anti-malarial treatment
Fig. 4 Node 2—Kenya and Madagascar. N number of children. The total line of each box represents the share of the total number of children who 
received any anti-malarial treatment
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countries also have higher than average proportions of 
women with at least a secondary education. Similar find-
ings were reported by a study in which febrile children of 
educated women were more likely to receive a malaria 
test than children of non-educated women [19]. Further-
more, there is substantial literature showing positive cor-
relations between children’s uptake of health services and 
mother’s level of education, independent of other social 
and economic factors [20, 21]. Educated mothers may be 
more open to advances in public health and medicine, 
more aware of malaria symptoms and related health risks, 
more trusting of providers, or more aware and better able 
to negotiate first-line services and treatment [22]. These 
characteristics may facilitate quick decision-making and 
therefore increase likelihood of prompt treatment. In 
SSA, women’s educational attainment is ever increas-
ing, which suggests that the trend of accelerating gains in 
children’s health is also likely to continue [23].
In Mozambique and Zanzibar, children whose moth-
ers were in their twenties were more likely to receive 
prompt and effective treatment than children whose 
mothers were older or younger. This is consistent with 
literature that suggests that adolescents are less likely to 
access maternal and child health services [24, 25]. Older 
Fig. 5 Node 3—Liberia. N number of children. The total line of each box represents the share of the total number of children who received any anti-
malarial treatment
Fig. 6 Node 5—Mozambique and Zanzibar. N number of children. The total line of each box represents the share of the total number of children 
who received any anti-malarial treatment
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mothers may be less likely to seek prompt and effective 
treatment if they are caring for multiple children. If they 
draw upon prior experience with febrile children, they 
also may be less inclined to follow new health messaging, 
thereby inhibiting prompt treatment. Further research on 
the relationships among mother’s age and education and 
prompt and effective treatment may help ensure that the 
mothers least likely to seek health services can and will 
access timely malaria treatment for their children.
In Angola, Ghana, Zambia, and Liberia, children from 
both the lowest and highest wealth quintiles were among 
those most likely to receive prompt and effective treat-
ment. Children from the lowest wealth quintile may be 
most likely to take advantage of free ACT offered in the 
public sector in Angola, Zambia, and Liberia [1]. On the 
other hand, children from the highest wealth quintile may 
be more likely to seek care outside the public sector or 
may be able to afford first-line ACT from private retail-
ers. Having access to these additional options for malaria 
care may facilitate prompt treatment, particularly if the 
locations are closer to home. This may change as com-
munity case management interventions improve access 
to prompt treatment by reducing the distance between 
febrile children and trained prescribers of ACT. Increas-
ing coverage of malaria interventions has improved 
equity [26–28], so it is possible that further gains in 
coverage may cancel inequities both within and across 
countries. Targeted research on equity will help ensure 
universal access to prompt and effective treatment.
Availability of prompt and effective treatment or qual-
ity of care issues may also explain why place of residence 
was a secondary predictor of prompt and effective treat-
ment in Uganda. Urban areas tend to have more options 
for health care (i.e., both public and private providers) 
and better access to preferred treatment compared to 
rural areas, which are mostly considered remote areas 
[29]. Affordable Medicines Facility-malaria evaluators 
reported higher availability of ACT in urban outlets in 
Uganda than rural areas, and even with an increase in 
availability at endline, rural areas remained behind [30]. 
This evidence supports the findings of the CHAID anal-
ysis, which showed that urban children in Uganda were 
more likely to receive prompt and effective treatment 
than rural children.
These are the predictors of which children are most 
likely to receive prompt and effective treatment, but a 
next step is strategizing for future interventions. The 
gain index from the CHAID analysis can help highlight 
whether it is more efficient to target specific groups 
or to invest in the overall population, with potential 
trickle-down effects to those groups. Increasing cover-
age in a particular node or cluster will yield correspond-
ing returns at the population level, quantified by the gain 
index. For example, the gain index of Cluster 3 is just 
70.9, showing that these children are much less likely to 
receive prompt and effective treatment than the over-
all population. Since Cluster 3 comprises only 14.4 % of 
children who received treatment with any anti-malarial 
medicine (i.e., this study’s target population), it is a rela-
tively small population that may be easier to target with 
an intervention to increase access to prompt treatment. 
However, it may not be cost effective to invest significant 
Fig. 7 Node 6—Uganda. N number of children. The total line of each box represents the share of the total number of children who received any 
anti-malarial treatment
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resources into a small group like this because the ben-
efits to national coverage goals may be limited. On the 
other hand, efforts to increase the proportion of children 
in Cluster 2 who receive prompt and effective treatment 
from 62.4 to 100 % may be more feasible since baseline 
coverage is higher. Investing in these children may also 
yield more visible public health impact since this clus-
ter represents a majority (53.1  %) of the target popula-
tion. These results may be useful in strategic planning 
for malaria control interventions at the national and 
subnational levels. Close monitoring can help malaria 
control programs determine if these children are being 
reached by future interventions in the quest for universal 
coverage.
Although this study presents informative findings, it 
does have limitations. It is difficult to track the extent to 
which patients with diagnosed malaria receive prompt 
and effective treatment using self-reported survey data 
because testing and treatment information are tradition-
ally not linked in survey data. Self-reported survey data 
also require caretakers to identify specific drugs, which 
may be especially difficult in countries where many 
malaria drugs are on the market, compared to countries 
where only ACT is available [31]. Finally, timeliness data 
rely on the ability of caretakers to determine whether 
treatment commenced the same day or next day as the 
onset of fever, which can be difficult to ascertain.
In addition, data were collected from surveys during 
a 6-year span from 2006 to 2012. This time difference 
in survey implementation could affect comparability in 
pooled results, as could the type of survey conducted 
(DHS, MIS, or A&PS). Furthermore, varying amounts 
of time between malaria policy implementation and 
ACT rollout could differently affect coverage and access 
to prompt and effective treatment within countries and 
across countries. There is also considerable variation in 
Table 5 Chi square automatic interaction detector gain index
N number of children
a Number of children who received any anti-malarial treatment per node (demographic size in the sample)
b Demographic size in percentage = (0.1/Σ0.1) × 100
c Number of children who received prompt treatment with ACT
d Demographic size among children who received prompt treatment with ACT in percentage = (0.3/Σ0.3) × 100




Node description Node Gain % prompte Indexf
Na %b Nc %d
A B C D E F G H
Cluster 1 2059 32.5 1504 37.5 73.0 115.3
 14 Mozambique and Zanzibar: children from 20 to 29 years old mothers 199 3.1 171 4.3 85.9 135.6
 15 Mozambique and Zanzibar: children from 15 to 19 years old mothers  
and 30–49 years old mothers
209 3.3 157 3.9 75.1 118.5
 16 Uganda: children from urban areas 334 5.3 240 6.0 71.9 113.4
 4 Malawi, Rwanda, Senegal, and Tanzania: all children 1317 20.8 936 23.3 71.1 112.1
Cluster 2 3366 53.1 2102 52.3 62.4 98.5
 11 Liberia: children from lowest and highest wealth quintiles 303 4.8 205 5.1 67.7 106.8
 17 Uganda: children from rural areas 1515 23.9 1000 24.9 66.0 104.2
 7 Angola, Ghana, and Zambia: children from mothers with secondary education and 
above
358 5.6 220 5.5 61.5 97.0
 13 Liberia: children from second and third quintiles 445 7.0 263 6.5 59.1 93.3
 9 Kenya and Madagascar: children from mothers with secondary education and above 111 1.8 63 1.6 56.8 89.6
 18 Angola, Ghana, and Zambia: children from mothers with primary or no education; 
children from lowest, fourth, and highest wealth quintiles
634 10.0 351 8.7 55.4 87.4
Cluster 3 912 14.4 410 10.2 45.0 70.9
 12 Liberia: children from the fourth wealth quintile 147 2.3 71 1.8 48.3 76.2
 19 Angola, Ghana, and Zambia: children from mothers with primary or no education; 
children from second and third wealth quintiles
388 6.1 176 4.4 45.4 71.6
 10 Kenya and Madagascar: children from mothers with primary or no education 377 5.9 163 4.1 43.2 68.2
Total 6337 100 4016 100 63.4 n/a
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the distribution of wealth quintiles and in equity of health 
interventions over time and among countries [32]. There 
is substantial subnational variation in malaria prevalence 
in several countries in SSA, which may affect expecta-
tions regarding ACT use and access to prompt treatment.
Finally, the data collected in these surveys do not exam-
ine additional factors related to access and social accepta-
bility of malaria treatment and services. This information 
could help refine the profiles of children who received 
prompt and effective treatment. Future CHAID analy-
ses could also include more complex covariates, such as 
source of treatment.
Conclusion
This study reveals that country of residence, mater-
nal education, place of residence, and socio-economic 
status are key predictors of prompt access to malaria 
treatment. The prominence of country as a predictor 
variable highlights the roles ACT policy implementa-
tion and rollout may play in access to prompt and effec-
tive treatment. The other key variables were of differing 
importance across countries, reminding implementers 
that understanding the context of their programmes is 
critical to success. Achieving universal coverage and 
the elimination agenda will require effective monitoring 
and early detection of coverage disparities within popu-
lations. Although national surveys provide a sporadic 
opportunity for this work, investing in routine surveil-
lance will improve real-time tracking of ACT coverage 
and corresponding action, in line with recent recom-
mendations from WHO’s Global Technical Strategy for 
Malaria.
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